Literature DB >> 7357081

Mapping the alpha-globin genes in an Algerian HbH patient and his family.

E Whitelaw, J Pagnier, G Verdier, T Henni, J Godet, R Williamson.   

Abstract

The organization of alpha-globin genes in normal white European, normal Algerian, and alpha-thalassemic Algerian DNA was examined by restriction endonuclease mapping using HindIII, HpaI, Bamhi, EcoRI, BgIII, and PstI. The results for normal DNA confirm and add to the findings of Surrey et al. and Orkin; the two alpha-genes are approximately 3.0 kb apart. The restriction enzymes BgIII and HpaL cut between the two alpha-genes. Four PstL sites are located: two surrounding each alpha-gene. The physical maps for a number of Algerian controls (normal alpha- and beta-globin biosynthesis profiles) are identical to that of the European controls. The Algerian alpha-thalassemic presenting with HbH disease was found to be homozygous for a 3.5-3.7 kb deletion at the alpha-gene locus, leaving one alpha-gene per chromosome. The patient's mother and father are both found to be heterozygous for this deletion. An unaffected sibling carries both normal chromosomes. The deletion could be the result of a Lepore-like crossover fusion event between the two alpha-globin genes, or of a 3.7 kb deletion of either the entire 5' alpha-gene or the entire 3' alpha-gene. The Algerian case of HbH disease studied differs from Asian cases in both the mode of inheritance and the molecular pathology of the alpha-thalassemia mutation. If this type of deletion is the major cause of Algerian alpha-thalassemia, it would explain the apparent absence of Hydrops fetalis in this geographical area.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7357081

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Prenatal diagnosis of alpha-thalassemia by polymerase chain reaction and dual restriction enzyme analysis.

Authors:  R V Lebo; R K Saiki; K Swanson; M A Montano; H A Erlich; M S Golbus
Journal:  Hum Genet       Date:  1990-08       Impact factor: 4.132

2.  Polymorphism of the Hinf I restriction site located 1 Kb 5' to the human beta-globin gene.

Authors:  G Kohen; N Philippe; J Godet
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

3.  Mapping the alpha-globin genes in Hb J Mexico carriers.

Authors:  G Trabuchet; F Morle; G Verdier; J Godet; M Benabadji; V M Nigon
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

4.  Deletions in the alpha-globin gene complex in alpha-thalassemic mice.

Authors:  J B Whitney; J Martinell; R A Popp; L B Russell; W F Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

5.  Alpha-globin gene deletions associated with alpha A and alpha G Philadelphia in an Algerian family that includes two Hb G homozygotes.

Authors:  F Morle; P Jaccoud; E Dorleac; M Motta; J Delaunay; J Godet
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

6.  Structural analysis of the 5' flanking region of the beta-globin gene in African sickle cell anemia patients: further evidence for three origins of the sickle cell mutation in Africa.

Authors:  Y Chebloune; J Pagnier; G Trabuchet; C Faure; G Verdier; D Labie; V Nigon
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

7.  Linkage of alpha G-Philadelphia to alpha-thalassemia in African-Americans .

Authors:  S Surrey; K Ohene-Frempong; E Rappaport; J Atwater; E Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

Review 8.  Thalassemic hemoglobinopathies.

Authors:  M H Steinberg; J G Adams
Journal:  Am J Pathol       Date:  1983-12       Impact factor: 4.307

9.  Alpha-globin loci in homozygous beta-thalassemia intermedia.

Authors:  P Triadou; C Lapoumeroulie; R Girot; D Labie
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

10.  alpha-Thalassaemia associated with the deletion of two nucleotides at position -2 and -3 preceding the AUG codon.

Authors:  F Morlé; B Lopez; T Henni; J Godet
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.